These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6284875)

  • 1. Opiate receptor: multiple effects of metal ions.
    Sadée W; Pfeiffer A; Herz A
    J Neurochem; 1982 Sep; 39(3):659-67. PubMed ID: 6284875
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
    Richards ML; Sadée W
    Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]diprenorphine binding to kappa-sites in guinea-pig and rat brain: evidence for apparent heterogeneity.
    Wood MS; Traynor JR
    J Neurochem; 1989 Jul; 53(1):173-8. PubMed ID: 2542456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of the mu-, delta-, and kappa-opiate receptor subtypes by guanyl nucleotides and metal ions.
    Pfeiffer A; Sadée W; Herz A
    J Neurosci; 1982 Jul; 2(7):912-7. PubMed ID: 6284888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H-diprenorphine is selective for mu opiate receptors in vivo.
    Frost JJ; Smith AC; Wagner HN
    Life Sci; 1986 Apr; 38(17):1597-606. PubMed ID: 3010021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms.
    Weyhenmeyer JA; Mack KJ
    Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of opioid binding sites using selective antagonists.
    Lawrence AJ; Traynor JR
    Prog Clin Biol Res; 1990; 328():121-4. PubMed ID: 1968257
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel opiate binding sites selective for benzomorphan drugs.
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of opiate receptor number in vivo: simultaneous kappa-receptor down-regulation and mu-receptor up-regulation following chronic agonist/antagonist treatment.
    Morris BJ; Herz A
    Neuroscience; 1989; 29(2):433-42. PubMed ID: 2542839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate.
    Kurowski M; Rosenbaum JS; Perry DC; Sadée W
    Brain Res; 1982 Oct; 249(2):345-52. PubMed ID: 6291717
    [No Abstract]   [Full Text] [Related]  

  • 11. Decrease in delta-opioid receptor density in rat brain after chronic [D-Ala2,D-Leu5]enkephalin treatment.
    Tao PL; Chang LR; Law PY; Loh HH
    Brain Res; 1988 Oct; 462(2):313-20. PubMed ID: 2847851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment.
    Attali B; Vogel Z
    Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioautography of binding of tritiated diprenorphine to opiate receptors in the rat.
    Pearson J; Brandeis L; Simon E; Hiller J
    Life Sci; 1980 Mar; 26(13):1047-52. PubMed ID: 6248701
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography.
    Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM
    J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of Mg2+ and other divalent cations on the binding of tritiated opioid ligands.
    Rodriguez FD; Bardaji E; Traynor JR
    J Neurochem; 1992 Aug; 59(2):467-72. PubMed ID: 1321228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sites of divalent cation modulation of delta opioid receptor binding.
    Szücs M; Oetting GM; Coscia CJ
    NIDA Res Monogr; 1986; 75():113-6. PubMed ID: 2828955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W; Rosenbaum JS; Herz A
    J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]diprenorphine receptor binding in vivo and in vitro.
    Sadée W; Perry DC; Rosenbaum JS; Herz A
    Eur J Pharmacol; 1982 Jul; 81(3):431-40. PubMed ID: 6288412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.